Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies

Brain, Behavior, and Immunity

Volumn 55, Issue , 2016, Pages 25-38

  Giovanoli, Sandra ^a   Weber Stadlbauer, Ulrike ^a,b   Schedlowski, Manfred ^c   Meyer, Urs ^a,b   Engler, Harald ^c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Autism; Cytokines; Inflammation; Maternal immune activation; Microglia; Poly(I:C); Schizophrenia; Synapse

Indexed keywords

CD68 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; POSTSYNAPTIC DENSITY PROTEIN 95; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID;

ACOUSTIC REFLEX; ADULT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRAIN MATURATION; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; FEMALE; GLIOSIS; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY GATING; STARTLE REFLEX; WHITE NOISE; AGE; ANIMAL; C57BL MOUSE; DISEASE MODEL; HIPPOCAMPUS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

AGE FACTORS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; IMMUNOLOGIC FACTORS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84948845532     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.09.015     Document Type: Article

References (130)

1. Aavani, T., Rana, S.A., Hawkes, R., Pittman, Q.J., in press. Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice. Cerebellum (Epub ahead of print [PMID: 25863812]).
2. Acarin, L., González, B., Castellano, B., Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur. J. Neurosci. 12 (2000), 3505–3520.
3. Arion, D., Unger, T., Lewis, D.A., Levitt, P., Mirnics, K., Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 62 (2007), 711–721.
4. Arsenault, D., St-Amour, I., Cisbani, G., Rousseau, L.S., Cicchetti, F., The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring. Brain Behav. Immun. 38 (2014), 77–90.
5. Atladóttir, H.Ó., Henriksen, T.B., Schendel, D.E., Parner, E.T., Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 130 (2012), e1447–e1454.
6. Basil, P., Li, Q., Dempster, E.L., Mill, J., Sham, P.C., Wong, C.C., McAlonan, G.M., Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. Transl. Psychiatry, 4, 2014, e434.
7. Bast, T., Feldon, J., Hippocampal modulation of sensorimotor processes. Prog. Neurobiol. 70 (2003), 319–345.
8. Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E.T., Südhof, T.C., SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297 (2002), 1525–1531.
9. Bilimoria, P.M., Stevens, B., Microglia function during brain development: new insights from animal models. Brain Res. 1617 (2015), 7–17.
10. Boksa, P., Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 24 (2010), 881–897.
11. Borrell, J., Vela, J.M., Arévalo-Martin, A., Molina-Holgado, E., Guaza, C., Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002), 204–215.
12. Braff, D.L., Geyer, M.A., Swerdlow, N.R., Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001), 234–258.
13. Brown, A.S., Derkits, E.J., Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 167 (2010), 261–280.
14. Brown, A.S., Sourander, A., Hinkka-Yli-Salomäki, S., McKeague, I.W., Sundvall, J., Surcel, H.M., Elevated maternal C-reactive protein and autism in a national birth cohort. Mol. Psychiatry 19 (2014), 259–264.
15. Burguillos, M.A., Use of meso-scale discovery™ to examine cytokine content in microglia cell supernatant. Methods Mol. Biol. 1041 (2013), 93–100.
16. Canetta, S., Sourander, A., Surcel, H.M., Hinkka-Yli-Salomäki, S., Leiviskä, J., Kellendonk, C., McKeague, I.W., Brown, A.S., Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am. J. Psychiatry 171 (2014), 960–968.
17. Canetta, S.E., Bao, Y., Co, M.D., Ennis, F.A., Cruz, J., Terajima, M., Shen, L., Kellendonk, C., Schaefer, C.A., Brown, A.S., Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am. J. Psychiatry 171 (2014), 557–563.
18. Cardon, M., Ron-Harel, N., Cohen, H., Lewitus, G.M., Schwartz, M., Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders. Mol. Psychiatry 15 (2010), 415–425.
19. Catts, V.S., Fung, S.J., Long, L.E., Joshi, D., Vercammen, A., Allen, K.M., Fillman, S.G., Rothmond, D.A., Sinclair, D., Tiwari, Y., Tsai, S.Y., Weickert, T.W., Shannon Weickert, C., Rethinking schizophrenia in the context of normal neurodevelopment. Front. Cell. Neurosci., 7, 2013, 60.
20. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflammation, 11, 2014, 98.
21. Clancy, B., Kersh, B., Hyde, J., Darlington, R.B., Anand, K.J., Finlay, B.L., Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 5 (2007), 79–94.
22. Colton, C., Wilcock, D.M., Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9 (2010), 174–191.
23. Connor, C.M., Dincer, A., Straubhaar, J., Galler, J.R., Houston, I.B., Akbarian, S., Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophrenia Res. 140 (2012), 175–184.
24. Cui, K., Ashdown, H., Luheshi, G.N., Boksa, P., Effects of prenatal immune activation on hippocampal neurogenesis in the rat. Schizophrenia Res. 113 (2009), 288–297.
25. Davydova, D., Marini, C., King, C., Klueva, J., Bischof, F., Romorini, S., Montenegro-Venegas, C., Heine, M., Schneider, R., Schröder, M.S., Altrock, W.D., Henneberger, C., Rusakov, D.A., Gundelfinger, E.D., Fejtova, A., Bassoon specifically controls presynaptic P/Q-type Ca(2+) channels via RIM-binding protein. Neuron 82 (2014), 181–194.
26. Dickerson, D.D., Wolff, A.R., Bilkey, D.K., Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia. J. Neurosci. 30 (2010), 12424–12431.
27. Dickerson, D.D., Overeem, K.A., Wolff, A.R., Williams, J.M., Abraham, W.C., Bilkey, D.K., Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia. Transl. Psychiatry, 4, 2014, e418.
28. Doorduin, J., de Vries, E.F., Willemsen, A.T., de Groot, J.C., Dierckx, R.A., Klein, H.C., Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 50 (2009), 1801–1807.
29. Eastwood, S.L., The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?. Int. Rev. Neurobiol. 59 (2004), 47–72.
30. Eastwood, S.L., Weickert, C.S., Webster, M.J., Herman, M.M., Kleinman, J.E., Harrison, P.J., Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age. Hippocampus 16 (2006), 645–654.
31. Ebrahimi-Fakhari, D., Sahin, M., Autism and the synapse: emerging mechanisms and mechanism-based therapies. Curr. Opin. Neurol. 28 (2015), 91–102.
32. Elferink, L.A., Scheller, R.H., Synaptic vesicle proteins and regulated exocytosis. Prog. Brain Res. 105 (1995), 79–85.
33. Erta, M., Quintana, A., Hidalgo, J., Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 8 (2012), 1254–1266.
34. Fillman, S.G., Cloonan, N., Catts, V.S., Miller, L.C., Wong, J., McCrossin, T., Cairns, M., Weickert, C.S., Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 18 (2013), 206–214.
35. Forrest, C.M., Khalil, O.S., Pisar, M., Smith, R.A., Darlington, L.G., Stone, T.W., Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol. Brain, 5, 2012, 22.
36. Forrest, C.M., Khalil, O.S., Pisar, M., Darlington, L.G., Stone, T.W., Prenatal inhibition of the tryptophan-kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus. Brain Res. 1504 (2013), 1–15.
37. Forrest, C.M., Khalil, O.S., Pisar, M., McNair, K., Kornisiuk, E., Snitcofsky, M., Gonzalez, N., Jerusalinsky, D., Darlington, L.G., Stone, T.W., Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway. Neuroscience 254 (2013), 241–259.
38. Franco, R., Fernández-Suárez, D., Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 131 (2015), 65–86.
39. Franklin, K.B.J., Paxinos, G., The Mouse Brain in Stereotaxic Coordinates. 2008, Elsevier Academic, Amsterdam.
40. Freidin, M., Bennett, M.V., Kessler, J.A., Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc. Natl. Acad. Sci. USA 89 (1992), 10440–10443.
41. Friedman, H.V., Bresler, T., Garner, C.C., Ziv, N.E., Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment. Neuron 27 (2000), 57–69.
42. Fung, S.J., Joshi, D., Fillman, S.G., Weickert, C.S., High white matter neuron density with elevated cortical cytokine expression in schizophrenia. Biol. Psychiatry, 75, 2014 e5-7.
43. Futai, K., Kim, M.J., Hashikawa, T., Scheiffele, P., Sheng, M., Hayashi, Y., Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat. Neurosci. 10 (2007), 186–195.
44. Garay, P.A., Hsiao, E.Y., Patterson, P.H., McAllister, A.K., Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav. Immun. 31 (2013), 54–68.
45. Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., Winter, C., Mortensen, P.B., Feldon, J., Schedlowski, M., Meyer, U., Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339 (2013), 1095–1099.
46. Glantz, L.A., Gilmore, J.H., Hamer, R.M., Lieberman, J.A., Jarskog, L.F., Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience 149 (2007), 582–591.
47. Gomez-Nicola, D., Perry, V.H., Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist 21 (2015), 169–184.
48. Gundersen, H.J., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96 (1988), 857–881.
49. Hadar, R., Soto-Montenegro, M.L., Götz, T., Wieske, F., Sohr, R., Desco, M., Hamani, C., Weiner, I., Pascau, J., Winter, C., Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course. Schizophrenia Res. 166 (2015), 238–247.
50. Hallermann, S., Fejtova, A., Schmidt, H., Weyhersmüller, A., Silver, R.A., Gundelfinger, E.D., Eilers, J., Bassoon speeds vesicle reloading at a central excitatory synapse. Neuron 68 (2010), 710–723.
51. Han, E.B., Stevens, C.F., Development regulates a switch between post- and presynaptic strengthening in response to activity deprivation. Proc. Natl. Acad. Sci. USA 106 (2009), 10817–10822.
52. Hanisch, U.K., Microglia as a source and target of cytokines. Glia 40 (2002), 140–155.
53. Harrison, P.J., The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174 (2004), 151–162.
54. Harvey, L., Boksa, P., Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev. Neurobiol. 72 (2012), 1335–1348.
55. Hollins, S.L., Zavitsanou, K., Walker, F.R., Cairns, M.J., Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure. Transl. Psychiatry, 4, 2014, e452.
56. Howard, C.V., Reed, M.G., Garland Science. 2005, BIOS Scientific, New York.
57. Juckel, G., Manitz, M.P., Brüne, M., Friebe, A., Heneka, M.T., Wolf, R.J., Microglial activation in a neuroinflammational animal model of schizophrenia–a pilot study. Schizophrenia Res. 131 (2011), 96–100.
58. Kasanetz, F., Manzoni, O.J., Maturation of excitatory synaptic transmission of the rat nucleus accumbens from juvenile to adult. J. Neurophysiol. 101 (2009), 2516–2527.
59. Kenk, M., Selvanathan, T., Rao, N., Suridjan, I., Rusjan, P., Remington, G., Meyer, J.H., Wilson, A.A., Houle, S., Mizrahi, R., Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophrenia Bull. 41 (2015), 85–93.
60. Khalil, O.S., Forrest, C.M., Pisar, M., Smith, R.A., Darlington, L.G., Stone, T.W., GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation. Immunopharmacol. Immunotoxicol. 35 (2013), 581–593.
61. Khalil, O.S., Pisar, M., Forrest, C.M., Vincenten, M.C., Darlington, L.G., Stone, T.W., Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring. Eur. J. Neurosci. 39 (2014), 1558–1571.
62. Kim, E., Sheng, M., PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5 (2004), 771–781.
63. Kim, J.H., Liao, D., Lau, L.F., Huganir, R.L., SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20 (1998), 683–691.
64. Kreisel, T., Frank, M.G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M.V., Maier, S.F., Yirmiya, R., Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 19 (2014), 699–709.
65. Kwon, M.S., Seo, Y.J., Lee, J.K., Lee, H.K., Jung, J.S., Jang, J.E., Park, S.H., Suh, H.W., The repeated immobilization stress increases IL-1beta immunoreactivities in only neuron, but not astrocyte or microglia in hippocampal CA1 region, striatum and paraventricular nucleus. Neurosci. Lett. 430 (2008), 258–263.
66. Lipina, T.V., Zai, C., Hlousek, D., Roder, J.C., Wong, A.H., Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J. Neurosci. 33 (2013), 7654–7666.
67. Liu, L., Li, Y., Van Eldik, L.J., Griffin, W.S., Barger, S.W., S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J. Neurochem. 92 (2005), 546–553.
68. Matz, J., Gilyan, A., Kolar, A., McCarvill, T., Krueger, S.R., Rapid structural alterations of the active zone lead to sustained changes in neurotransmitter release. Proc. Natl. Acad. Sci. USA 107 (2010), 8836–8841.
69. McMahon, H.T., Bolshakov, V.Y., Janz, R., Hammer, R.E., Siegelbaum, S.A., Südhof, T.C., Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc. Natl. Acad. Sci. USA 93 (1996), 4760–4764.
70. Mendoza Schulz, A., Jing, Z., Sánchez Caro, J.M., Wetzel, F., Dresbach, T., Strenzke, N., Wichmann, C., Moser, T., Bassoon-disruption slows vesicle replenishment and induces homeostatic plasticity at a CNS synapse. EMBO J. 33 (2014), 512–527.
71. Meyer, U., Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 75 (2014), 307–315.
72. Meyer, U., Feldon, J., Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav. Brain Res. 204 (2009), 322–334.
73. Meyer, U., Feldon, J., Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 90 (2010), 285–326.
74. Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29 (2005), 913–947.
75. Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B.K., Feldon, J., The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26 (2006), 4752–4762.
76. Meyer, U., Engler, A., Weber, L., Schedlowski, M., Feldon, J., Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 154 (2008), 701–709.
77. Meyer, U., Knuesel, I., Nyffeler, M., Feldon, J., Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology 208 (2010), 531–543.
78. Miller, B.J., Culpepper, N., Rapaport, M.H., Buckley, P., Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 42 (2013), 92–100.
79. Missault, S., Van den Eynde, K., Vanden Berghe, W., Fransen, E., Weeren, A., Timmermans, J.P., Kumar-Singh, S., Dedeurwaerdere, S., The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav. Immun. 42 (2014), 138–146.
80. Morgan, J.T., Chana, G., Pardo, C.A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., Everall, I.P., Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68 (2010), 368–376.
81. Nyffeler, M., Meyer, U., Yee, B.K., Feldon, J., Knuesel, I., Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143 (2006), 51–62.
82. Nyffeler, M., Zhang, W.N., Feldon, J., Knuesel, I., Differential expression of PSD proteins in age-related spatial learning impairments. Neurobiol. Aging 28 (2007), 143–155.
83. Oh-Nishi, A., Obayashi, S., Sugihara, I., Minamimoto, T., Suhara, T., Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring. Brain Res. 1363 (2010), 170–179.
84. Onore, C., Careaga, M., Ashwood, P., The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 26 (2012), 383–392.
85. Pacheco-López, G., Giovanoli, S., Langhans, W., Meyer, U., Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophrenia Bull. 39 (2013), 319–329.
86. Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T.A., Guiducci, E., Dumas, L., Ragozzino, D., Gross, C.T., Synaptic pruning by microglia is necessary for normal brain development. Science 333 (2011), 1456–1458.
87. Parboosing, R., Bao, Y., Shen, L., Schaefer, C.A., Brown, A.S., Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 70 (2013), 677–685.
88. Pasternak, O., Kubicki, M., Shenton, M.E., in press. In vivo imaging of neuroinflammation in schizophrenia. Schizophrenia Res. (Epub ahead of print [PMID: 26048294]).
89. Perry, V.H., O'Connor, V., The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. ASN Neuro., 2, 2010, e00047.
90. Pineda, E., Shin, D., You, S.J., Auvin, S., Sankar, R., Mazarati, A., Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann. Neurol. 74 (2013), 11–19.
91. Piontkewitz, Y., Arad, M., Weiner, I., Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol. Psychiatry 70 (2011), 842–851.
92. Piontkewitz, Y., Arad, M., Weiner, I., Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 62 (2012), 1273–1289.
93. Piontkewitz, Y., Bernstein, H.G., Dobrowolny, H., Bogerts, B., Weiner, I., Keilhoff, G., Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav. Immun., 26, 2012 353-263.
94. Pratt, L., Ni, L., Ponzio, N.M., Jonakait, G.M., Maternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: role of interleukin-6. Pediatr. Res. 74 (2013), 393–401.
95. Ransohoff, R.M., Perry, V.H., Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27 (2009), 119–145.
96. Rao, J.S., Kellom, M., Kim, H.W., Rapoport, S.I., Reese, E.A., Neuroinflammation and synaptic loss. Neurochem. Res. 37 (2012), 903–910.
97. Reisinger, S., Khan, D., Kong, E., Berger, A., Pollak, A., Pollak, D.D., The Poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. Pharmacol. Ther. 149 (2015), 213–226.
98. Richetto, J., Calabrese, F., Meyer, U., Riva, M.A., Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice. Brain Behav. Immun. 33 (2013), 190–200.
99. Richetto, J., Calabrese, F., Riva, M.A., Meyer, U., Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophrenia Bull. 40 (2014), 351–361.
100. Savanthrapadian, S., Wolff, A.R., Logan, B.J., Eckert, M.J., Bilkey, D.K., Abraham, W.C., Enhanced hippocampal neuronal excitability and LTP persistence associated with reduced behavioral flexibility in the maternal immune activation model of schizophrenia. Hippocampus 23 (2013), 1395–1409.
101. Schafer, D.P., Stevens, B., Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system. Curr. Opin. Neurobiol. 23 (2013), 1034–1040.
102. Schafer, D.P., Lehrman, E.K., Kautzman, A.G., Koyama, R., Mardinly, A.R., Yamasaki, R., Ransohoff, R.M., Greenberg, M.E., Barres, B.A., Stevens, B., Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74 (2012), 691–705.
103. Scheiffele, P., Fan, J., Choih, J., Fetter, R., Serafini, T., Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 (2000), 657–669.
104. Schmitt, U., Tanimoto, N., Seeliger, M., Schaeffel, F., Leube, R.E., Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. Neuroscience 162 (2009), 234–243.
105. Schoch, S., Gundelfinger, E.D., Molecular organization of the presynaptic active zone. Cell Tissue Res. 326 (2006), 379–391.
106. Schröder, M.S., Stellmacher, A., Romorini, S., Marini, C., Montenegro-Venegas, C., Altrock, W.D., Gundelfinger, E.D., Fejtova, A., Regulation of presynaptic anchoring of the scaffold protein Bassoon by phosphorylation-dependent interaction with 14-3-3 adaptor proteins. PLoS One, 8, 2013, e58814.
107. Schwarcz, R., Bruno, J.P., Muchowski, P.J., Wu, H.Q., Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13 (2012), 465–477.
108. Sheng, M., Molecular organization of the postsynaptic specialization. Proc. Natl. Acad. Sci. USA 98 (2001), 7058–7061.
109. Sheng, M., Hoogenraad, C.C., The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu. Rev. Biochem. 76 (2007), 823–847.
110. Shin, O.H., Exocytosis and synaptic vesicle function. Compr. Physiol. 4 (2014), 149–175.
111. Sisková, Z., Page, A., O'Connor, V., Perry, V.H., Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am. J. Pathol. 175 (2009), 1610–1621.
112. Smolders, S., Smolders, S.M., Swinnen, N., Gärtner, A., Rigo, J.M., Legendre, P., Brône, B., Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo. Front. Cell. Neurosci., 9, 2015, 301.
113. Spear, L.P., The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000), 417–463.
114. Swerdlow, N.R., Weber, M., Qu, Y., Light, G.A., Braff, D.L., Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 199 (2008), 331–388.
115. Tamminga, C.A., Stan, A.D., Wagner, A.D., The hippocampal formation in schizophrenia. Am. J. Psychiatry 167 (2010), 1178–1193.
116. Tang, B., Jia, H., Kast, R.J., Thomas, E.A., Epigenetic changes at gene promoters in response to immune activation in utero. Brain Behav. Immun. 30 (2013), 168–175.
117. Tetreault, N.A., Hakeem, A.Y., Jiang, S., Williams, B.A., Allman, E., Wold, B.J., Allman, J.M., Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 42 (2012), 2569–2584.
118. van Berckel, B.N., Bossong, M.G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A.D., Cahn, W., Lammertsma, A.A., Kahn, R.S., Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 64 (2008), 820–822.
119. Van den Eynde, K., Missault, S., Fransen, E., Raeymaekers, L., Willems, R., Drinkenburg, W., Timmermans, J.P., Kumar-Singh, S., Dedeurwaerdere, S., Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav. Brain Res. 258 (2014), 179–186.
120. Varty, G.B., Marsden, C.A., Higgins, G.A., Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats. Brain Res. 824 (1999), 197–203.
121. Volk, D.W., Chitrapu, A., Edelson, J.R., Roman, K.M., Moroco, A.E., Lewis, D.A., in press. Molecular mechanisms and timing of cortical immune activation in schizophrenia. Am. J. Psychiatry (Epub ahead of print [PMID: 26133963]).
122. Vuillermot, S., Weber, L., Feldon, J., Meyer, U., A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J. Neurosci. 30 (2010), 1270–1287.
123. Webster, M.J., Elashoff, M., Weickert, C.S., Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int. J. Dev. Neurosci. 29 (2011), 225–236.
124. Wiedenmann, B., Franke, W.W., Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41 (1985), 1017–1028.
125. Willi, R., Harmeier, A., Giovanoli, S., Meyer, U., Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease. Neuropharmacology 73 (2013), 56–65.
126. Wolff, A.R., Bilkey, D.K., The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav. Brain Res. 213 (2010), 323–327.
127. Wolff, A.R., Bilkey, D.K., Prenatal immune activation alters hippocampal place cell firing characteristics in adult animals. Brain Behav. Immun. 48 (2015), 232–243.
128. Zhai, R., Olias, G., Chung, W.J., Lester, R.A., tom Dieck, S., Langnaese, K., Kreutz, M.R., Kindler, S., Gundelfinger, E.D., Garner, C.C., Temporal appearance of the presynaptic cytomatrix protein bassoon during synaptogenesis. Mol. Cell. Neurosci. 15 (2000), 417–428.
129. Zhang, Z., van Praag, H., Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice. Brain Behav. Immun. 45 (2015), 60–70.
130. Zhu, F., Zheng, Y., Liu, Y., Zhang, X., Zhao, J., Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic–polyribocytidilic acid. Psychiatry Res. 219 (2014), 680–686.